Glenmede Trust Co. NA Purchases 2,655 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Glenmede Trust Co. NA raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.2% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 53,565 shares of the medical equipment provider's stock after purchasing an additional 2,655 shares during the period. Glenmede Trust Co. NA's holdings in Intuitive Surgical were worth $26,315,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of ISRG. Massachusetts Financial Services Co. MA bought a new stake in Intuitive Surgical in the third quarter valued at approximately $558,807,000. International Assets Investment Management LLC increased its position in shares of Intuitive Surgical by 49,383.6% in the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider's stock valued at $535,788,000 after buying an additional 1,088,415 shares in the last quarter. FMR LLC raised its stake in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock worth $5,389,765,000 after buying an additional 838,793 shares during the period. Strategic Financial Concepts LLC grew its stake in Intuitive Surgical by 40,221.4% in the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider's stock valued at $1,184,000 after acquiring an additional 265,461 shares during the period. Finally, Manning & Napier Advisors LLC acquired a new stake in shares of Intuitive Surgical during the second quarter worth about $91,466,000. Institutional investors own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Oppenheimer reiterated a "market perform" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Piper Sandler reiterated an "overweight" rating and issued a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Truist Financial raised their price objective on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a "buy" rating in a report on Monday, October 14th. Evercore ISI reaffirmed a "cautious" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Robert W. Baird boosted their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an "outperform" rating in a research report on Thursday, October 17th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $526.06.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 2,128 shares of the company's stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the completion of the transaction, the senior vice president now owns 273 shares of the company's stock, valued at $140,595. This represents a 88.63 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, General Counsel Gary Loeb sold 300 shares of Intuitive Surgical stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $475.00, for a total transaction of $142,500.00. Following the sale, the general counsel now owns 1,595 shares in the company, valued at approximately $757,625. This represents a 15.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 50,459 shares of company stock worth $26,080,251 over the last quarter. Corporate insiders own 0.80% of the company's stock.

Intuitive Surgical Stock Performance

ISRG opened at $538.55 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $304.50 and a 52-week high of $552.00. The firm has a market cap of $191.82 billion, a P/E ratio of 86.58, a price-to-earnings-growth ratio of 5.28 and a beta of 1.39. The business's fifty day moving average is $507.94 and its 200-day moving average is $466.79.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, research analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.